Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Levin

Showing results (1321-1330 of 1,338) with videos related to

Pageof 134
Sort By:
Journal of Substance Use and Addiction Treatment|November 11, 2024
Development of a brief stigma and perceptions questionnaire for pharmacists: An exploratory factor analysis approach in New York state counties enrolled in the healing communities studyDawn Goddard-Eckrich, Kyle Grealis, Nabila El-Bassel, et al.
Spanish Journal of Psychiatry and Mental Health|June 21, 2020
Validity of the ADHD module of the Mini International Neuropsychiatric Interview PLUS for screening of adult ADHD in treatment seeking substance use disorder patients: ADHD screening with MINI-PlusRaul Felipe Palma-Álvarez, Csaba Barta, Pieter Jan Carpentier, et al.
Drug and Alcohol Dependence|May 11, 2013
Validity of the Adult ADHD Self-Report Scale (ASRS) as a screener for adult ADHD in treatment seeking substance use disorder patientsGeurt van de Glind, Wim van den Brink, Maarten W J Koeter, et al.
JAMA Psychiatry|November 30, 2022
Clinical Trial Design Challenges and Opportunities for Emerging Treatments for Opioid Use Disorder: A ReviewBrian D Kiluk, Bethea A Kleykamp, Sandra D Comer, et al.
Addiction (Abingdon, England)|October 15, 2013
Psychiatric comorbidity in treatment-seeking substance use disorder patients with and without attention deficit hyperactivity disorder: results of the IASP studyKatelijne van Emmerik-van Oortmerssen, Geurt van de Glind, Maarten W J Koeter, et al.
Drug and Alcohol Dependence|October 26, 2013
Variability in the prevalence of adult ADHD in treatment seeking substance use disorder patients: results from an international multi-center study exploring DSM-IV and DSM-5 criteriaGeurt van de Glind, Maija Konstenius, Maarten W J Koeter, et al.
Journal of Attention Disorders|February 29, 2016
Persistence and Subtype Stability of ADHD Among Substance Use Disorder Treatment SeekersSharlene Kaye, Josep Antoni Ramos-Quiroga, Geurt van de Glind, et al.
Cell Reports|May 18, 2023
Architecture of androgen receptor pathways amplifying glucagon-like peptide-1 insulinotropic action in male pancreatic β cellsWeiwei Xu, M M Fahd Qadir, Daniela Nasteska, et al.
Nature Medicine|June 8, 2023
Signaling-specific inhibition of the CB<sub>1</sub> receptor for cannabis use disorder: phase 1 and phase 2a randomized trialsMargaret Haney, Monique Vallée, Sandy Fabre, et al.
Journal of Substance Use and Addiction Treatment|November 27, 2025
The impact of the communities that HEAL intervention on the provision of jail-based medication for opioid use disorder & linkage programs at release: Results from a randomized, wait-list controlled trialCarrie B Oser, Joel G Sprunger, Tim Hunt, et al.
Pageof 134

Showing results (1321-1330 of 1,338) with videos related to

Sort By:
Pageof 134
Journal of Substance Use and Addiction Treatment|November 11, 2024
Development of a brief stigma and perceptions questionnaire for pharmacists: An exploratory factor analysis approach in New York state counties enrolled in the healing communities studyDawn Goddard-Eckrich, Kyle Grealis, Nabila El-Bassel, et al.
Spanish Journal of Psychiatry and Mental Health|June 21, 2020
Validity of the ADHD module of the Mini International Neuropsychiatric Interview PLUS for screening of adult ADHD in treatment seeking substance use disorder patients: ADHD screening with MINI-PlusRaul Felipe Palma-Álvarez, Csaba Barta, Pieter Jan Carpentier, et al.
Drug and Alcohol Dependence|May 11, 2013
Validity of the Adult ADHD Self-Report Scale (ASRS) as a screener for adult ADHD in treatment seeking substance use disorder patientsGeurt van de Glind, Wim van den Brink, Maarten W J Koeter, et al.
JAMA Psychiatry|November 30, 2022
Clinical Trial Design Challenges and Opportunities for Emerging Treatments for Opioid Use Disorder: A ReviewBrian D Kiluk, Bethea A Kleykamp, Sandra D Comer, et al.
Addiction (Abingdon, England)|October 15, 2013
Psychiatric comorbidity in treatment-seeking substance use disorder patients with and without attention deficit hyperactivity disorder: results of the IASP studyKatelijne van Emmerik-van Oortmerssen, Geurt van de Glind, Maarten W J Koeter, et al.
Drug and Alcohol Dependence|October 26, 2013
Variability in the prevalence of adult ADHD in treatment seeking substance use disorder patients: results from an international multi-center study exploring DSM-IV and DSM-5 criteriaGeurt van de Glind, Maija Konstenius, Maarten W J Koeter, et al.
Journal of Attention Disorders|February 29, 2016
Persistence and Subtype Stability of ADHD Among Substance Use Disorder Treatment SeekersSharlene Kaye, Josep Antoni Ramos-Quiroga, Geurt van de Glind, et al.
Cell Reports|May 18, 2023
Architecture of androgen receptor pathways amplifying glucagon-like peptide-1 insulinotropic action in male pancreatic β cellsWeiwei Xu, M M Fahd Qadir, Daniela Nasteska, et al.
Nature Medicine|June 8, 2023
Signaling-specific inhibition of the CB<sub>1</sub> receptor for cannabis use disorder: phase 1 and phase 2a randomized trialsMargaret Haney, Monique Vallée, Sandy Fabre, et al.
Journal of Substance Use and Addiction Treatment|November 27, 2025
The impact of the communities that HEAL intervention on the provision of jail-based medication for opioid use disorder & linkage programs at release: Results from a randomized, wait-list controlled trialCarrie B Oser, Joel G Sprunger, Tim Hunt, et al.
Pageof 134